Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?

Insulin-like growth factor type I (IGF-I) is an important promoter in the tumorigenesis of several extracranial and intracranial neoplasms. In astrocytic-cell tumors, the role of autocrine and paracrine IGF-I expression in enhancing tumoral progression is well established. However, the influence of...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Fernandez, A, Karavitaki, N, Ansorge, O, Fazal-Sanderson, V, Wass, J
Format:	Journal article
Sprog:	English
Udgivet:	2008

Lignende værker

The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
af: Karavitaki, N, et al.
Udgivet: (2009)

Hypercalcaemia in acromegaly is not always due to men-1
af: Zabuliene, L, et al.
Udgivet: (2005)

Acromegaly: Treatment with somatostatin analogs
af: Karavitaki, N, et al.
Udgivet: (2005)

Anaplastic astrocytoma
af: Xiao-ling YAN
Udgivet: (2014-08-01)

Pegvisomant: a new treatment modality for acromegaly.
af: Karavitaki, N, et al.
Udgivet: (2004)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
af: Karavitaki, N, et al.
Udgivet: (2008)

Anaplastic astrocytoma, IDH-mutant
af: Xiao-ling YAN
Udgivet: (2017-09-01)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.
af: Pereira, E, et al.
Udgivet: (2010)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
af: Chahal, H, et al.
Udgivet: (2010)

A rare brainstem anaplastic astrocytoma
af: You Rongjiao, et al.
Udgivet: (2022-09-01)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
af: Chahal, H, et al.
Udgivet: (2011)

Survival of patients treated with radiation therapy for anaplastic astrocytoma
af: Barker Christopher A., et al.
Udgivet: (2014-12-01)

A cystic anaplastic ependymoma mimicking a pilocytic astrocytoma
af: Nguyen Minh Duc, MD
Udgivet: (2023-02-01)

Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
af: Karam Khaddour, et al.
Udgivet: (2020-10-01)

Glioblastoma and Anaplastic Astrocytoma: Differentiation Using MRI Texture Analysis
af: Zerong Tian, et al.
Udgivet: (2019-09-01)

New treatments for acromegaly.
af: Wass, J, et al.
Udgivet: (1998)

Silent corticotroph adenomas.
af: Karavitaki, N, et al.
Udgivet: (2007)

A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma.
af: Soumya Alige Mahabala Rao, et al.
Udgivet: (2014-01-01)

Acute toxicity of temozolomide for the treatment of anaplastic astrocytoma: A case report
af: Yunni Diansari, et al.
Udgivet: (2021-01-01)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
af: Wass, J
Udgivet: (1997)

Long-term effects of radiotherapy for acromegaly.
af: Wass, J
Udgivet: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
af: Wass, J
Udgivet: (2003)

Fascicular multiple ocular motor nerve paresis as first presentation of anaplastic astrocytoma
af: Gupta Bhaskar, et al.
Udgivet: (2007-01-01)

Approaches for the prevention and treatment of venous thromboembolism in a patient with anaplastic astrocytoma: a case report
af: M. G. Pavlova, et al.
Udgivet: (2021-04-01)

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
af: Karavitaki, N, et al.
Udgivet: (2005)

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
af: Arne Christians, et al.
Udgivet: (2019-10-01)

Investigation protocol: acromegaly and its investigation.
af: Duncan, E, et al.
Udgivet: (1999)

Meta-analysis of glioblastoma multiforme <it>versus </it>anaplastic astrocytoma identifies robust gene markers
af: Park Peter J, et al.
Udgivet: (2009-09-01)

What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics.
af: Gürlek, A, et al.
Udgivet: (2007)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
af: Wass, J
Udgivet: (2003)

Nasal‐alar invasive cutaneous aspergillosis in a patient with anaplastic astrocytoma: A case report
af: Adham A. Aljariri, et al.
Udgivet: (2021-04-01)

Overexpression of c-<it>erb</it>B2 is a negative prognostic factor in anaplastic astrocytomas
af: Gulati Michel, et al.
Udgivet: (2010-03-01)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
af: Grossman, A, et al.
Udgivet: (1986)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
af: Grossman, A, et al.
Udgivet: (1985)

Diabetes mellitus in acromegaly: prevalence, pathophysiological particulars and treatment strategies
af: Irena A. Ilovayskaya, et al.
Udgivet: (2023-12-01)

Coincidence of Anaplastic Lymphoma of the Stomach with Kaposi ’s Sarcoma: A Rare Presentation
af: Sohaila Fatima, et al.
Udgivet: (2019-04-01)

Acute octreotide suppression test (100 mu g sc): a valuable tool for predicting the long-term response to the long-acting somatostatin analogs in patients with active acromegaly
af: Karavitaki, N, et al.
Udgivet: (2005)

Recent advances in the management of acromegaly [version 1; referees: 2 approved]
af: Georgia Ntali, et al.
Udgivet: (2015-12-01)

Impact of gross-total resection versus other extent of resections for the overall survival of anaplastic astrocytoma
af: Dipak Chaulagain, et al.
Udgivet: (2023-09-01)

The curious case of commitment to religion and prayer in extreme long term survival anaplastic astrocytoma patient
af: Goran Tasić, et al.
Udgivet: (2023-03-01)